Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Cash from Operations (2016 - 2025)

China Pharma Holdings filings provide 16 years of Cash from Operations readings, the most recent being 73729.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 75.32% to 73729.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 70000.0, a 117.24% increase, with the full-year FY2025 number at 70000.0, up 117.24% from a year prior.
  • Cash from Operations hit 73729.0 in Q4 2025 for China Pharma Holdings, up from 236987.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1007286.0 in Q3 2023 to a low of 1468214.0 in Q1 2023.
  • Median Cash from Operations over the past 5 years was 66363.0 (2024), compared with a mean of 84756.6.
  • Biggest five-year swings in Cash from Operations: surged 1438.41% in 2024 and later tumbled 404.74% in 2025.
  • China Pharma Holdings' Cash from Operations stood at 198112.0 in 2021, then surged by 395.08% to 584594.0 in 2022, then crashed by 103.82% to 22323.0 in 2023, then surged by 1438.41% to 298773.0 in 2024, then tumbled by 75.32% to 73729.0 in 2025.
  • The last three reported values for Cash from Operations were 73729.0 (Q4 2025), 236987.0 (Q3 2025), and 293258.0 (Q2 2025) per Business Quant data.